Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107770734 | 10777073 | 4 | F | 20160818 | 20150209 | 20160823 | PER | US-PFIZER INC-2015050932 | PFIZER | 66.00 | YR | F | Y | 0.00000 | 20160823 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107770734 | 10777073 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, 2X/DAY | U | 21446 | 100 | MG | CAPSULE, HARD | BID | |||||
| 107770734 | 10777073 | 2 | C | FENTANYL. | FENTANYL | 1 | Topical | UNK (25MCG/HR FILM, EXTENDED RELEASE, 1 PATCH APPLIED TOPICALLY EVRY 72 HOURS) | 0 | ||||||||||
| 107770734 | 10777073 | 3 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | UNK, 1X/DAY (1 CAPS(S) ORALLY QHS) | 0 | 100 | MG | CAPSULE | |||||||
| 107770734 | 10777073 | 4 | C | ATIVAN | LORAZEPAM | 1 | Oral | 1 MG, AS NEEDED (1/2 TO 1 TAB (S) ORALLY BID PRN) | 0 | 1 | MG | TABLET | |||||||
| 107770734 | 10777073 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, 2X/DAY | 0 | 500 | MG | TABLET | BID | ||||||
| 107770734 | 10777073 | 6 | C | PHENERGAN | PROMETHAZINE HYDROCHLORIDE | 1 | Rectal | 25 MG, 4X/DAY ( 1 SUPP (S) RECTALLY EVERY 6 HOURS) | 0 | 25 | MG | SUPPOSITORY | QID | ||||||
| 107770734 | 10777073 | 7 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, 1X/DAY (EVERY DAY) | 0 | 75 | MG | TABLET | QD | ||||||
| 107770734 | 10777073 | 8 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | Oral | 25 MG, 3X/DAY | 0 | 25 | MG | TABLET | TID | ||||||
| 107770734 | 10777073 | 9 | C | SOMA | CARISOPRODOL | 1 | Oral | 350 MG, 4X/DAY | 0 | 350 | MG | TABLET | QID | ||||||
| 107770734 | 10777073 | 10 | C | HYDROCHLOROTHIAZIDE W/TRIAMTERENE | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | Oral | 1 DF, 1X/DAY (HYDROCHLOROTHIAZIDE- 25MG, TRIAMTERENE- 37.5MG) | 0 | 1 | DF | TABLET | QD | ||||||
| 107770734 | 10777073 | 11 | C | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | Oral | 2 DF, 4X/DAY | 0 | 2 | DF | CAPSULE | QID | ||||||
| 107770734 | 10777073 | 12 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | 1 DF, 4X/DAY (OXYCODONE HYDROCHLORIDE-10MG,PARACETAMOL-325MG) | 0 | 1 | DF | TABLET | QID | ||||||
| 107770734 | 10777073 | 13 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 40 MG, 1X/DAY (AT BEDTIME) | 0 | 40 | MG | TABLET | QD | ||||||
| 107770734 | 10777073 | 14 | C | KLOR-CON M20 | POTASSIUM CHLORIDE | 1 | Oral | 1 DF, DAILY | 0 | 1 | DF | MODIFIED-RELEASE TABLET | |||||||
| 107770734 | 10777073 | 15 | C | LABETALOL | LABETALOLLABETALOL HYDROCHLORIDE | 1 | Oral | 200 MG, 2X/DAY | 0 | 200 | MG | TABLET | BID |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107770734 | 10777073 | Malaise | |
| 107770734 | 10777073 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107770734 | 10777073 | 1 | 20160113 | 0 | ||
| 107770734 | 10777073 | 4 | 20160205 | 0 | ||
| 107770734 | 10777073 | 5 | 20151218 | 0 | ||
| 107770734 | 10777073 | 6 | 20151201 | 0 | ||
| 107770734 | 10777073 | 7 | 20151113 | 0 | ||
| 107770734 | 10777073 | 8 | 20150702 | 0 | ||
| 107770734 | 10777073 | 11 | 20150602 | 0 | ||
| 107770734 | 10777073 | 14 | 20140520 | 0 |